1. THAP1: Role in Mouse Embryonic Stem Cell Survival and Differentiation
- Author
-
Francesca Aguilo, Zuchra Zakirova, Katie Nolan, Ryan Wagner, Rajal Sharma, Megan Hogan, Chengguo Wei, Yifei Sun, Martin J. Walsh, Kevin Kelley, Weijia Zhang, Laurie J. Ozelius, Pedro Gonzalez-Alegre, Thomas P. Zwaka, and Michelle E. Ehrlich
- Subjects
Thanatos-associated protein domain-containing apoptosis-associated protein 1 ,THAP1 ,dystonia ,differentiation ,survival ,embryonic stem cells ,transcriptomics ,neuroectodermal differentiation ,apoptosis ,zinc finger transcription factor ,Medicine (General) ,R5-920 ,Biology (General) ,QH301-705.5 - Abstract
THAP1 (THAP [Thanatos-associated protein] domain-containing, apoptosis-associated protein 1) is a ubiquitously expressed member of a family of transcription factors with highly conserved DNA-binding and protein-interacting regions. Mutations in THAP1 cause dystonia, DYT6, a neurologic movement disorder. THAP1 downstream targets and the mechanism via which it causes dystonia are largely unknown. Here, we show that wild-type THAP1 regulates embryonic stem cell (ESC) potential, survival, and proliferation. Our findings identify THAP1 as an essential factor underlying mouse ESC survival and to some extent, differentiation, particularly neuroectodermal. Loss of THAP1 or replacement with a disease-causing mutation results in an enhanced rate of cell death, prolongs Nanog, Prdm14, and/or Rex1 expression upon differentiation, and results in failure to upregulate ectodermal genes. ChIP-Seq reveals that these activities are likely due in part to indirect regulation of gene expression.
- Published
- 2017
- Full Text
- View/download PDF